Event Schedule
Have a look at Schedule
Welcome Coffee, Registration & Itinerary Collection
Opening Remarks
Prabhnihal Josan
Senior Key Accounts Manager
World BI
Chair Welcome Address
Leo Kirkovsky
Director, Clinical Assay Group (CAG)
Presentation 1: Some Challenges with ADC Development with Bio-analysis and Clinical Pharmacology As Examples
Leo Kirkovsky
Director, Clinical Assay Group (CAG)
Presentation 2: Bench-to-bedside Translational Research: Examples of Resources and Basic and Translational Research
Attila Seyhan
Director of Translational Oncology Operations | Associate Research Professor
Brown University
Coffee Break & Networking Session
Presentation 3: Generative AI for small molecule drug discovery
Ho Leung
Founder, Computational/AI Drug Discovery Chemistry
Rise Bio
Presentation 4: Artificial Intelligence and Machine Learning (AI/ML) in drug development
Marsha Samson
Senior Regulatory Analyst
Food and Drug Administration (FDA) – USPHS
Give and Take Chat: Tapping into the drug discovery potential of AI/ML
Moderator
Ho Leung
Founder, Computational/AI Drug Discovery Chemistry
Rise Bio
Panelist:
Dr. Abhishek Jha
Co-Founder & CEO
Elucidata
Lunch Break
Presentation 5: Integration of Physics and Machine Learning for Challenging Drug Discovery Targets
Rafal Wiewiora
Principal, Computational Biophysics
Psivant Therapeutics
Presentation 6: Recent results from massively multitask Profile-QSAR models as accurate as 4-point IC50s for 9000 assays.
Eric Martin
Director, Computational Chemistry
Novartis
Presentation 7: A Comparison of Drug Target Deconvolution Techniques for a CDK9
Eric Miele
Associate Director of Proteomics
AstraZeneca
Presentation 8: Novel Insights Into Therapeutic Targeting of KRAS:Conventional Wisdom is Not Always Right
Imran Khan
Senior Scientist
Bristol Myers Squibb
Presentation 9: Quantitative Systems Pharmacology Modeling and its Application for Hypertrophic Cardiomyopathy
Limei Cheng, PhD
Director | QSP Cardiovascular Lead
Bristol Myers Squibb
Coffee Break & Networking Session
Pitch Session: Jubilant Biosys
Fire Side Chat: What comes "next" for drug research and development
Moderator
Limei Cheng, PhD
Director | QSP Cardiovascular Lead
Bristol Myers Squibb
Panelist:
Attila Seyhan
Director of Translational Oncology Operations | Associate Research Professor
Brown University
Chair Closing Remarks
Leo Kirkovsky
Director, Clinical Assay Group (CAG)
End of Day 1
Welcome Coffee, Registration & Itinerary Collection
Opening Remarks
Prabhnihal Josan
Senior Key Accounts Manager
World BI
Chair Welcome Address
Leo Kirkovsky
Director, Clinical Assay Group (CAG)
Presentation 10: Role of AI ML in Advancing Drug Discovery and Development
Prasun Mishra, PhD
Founder and CEO
American Association for Precision Medicine and Agility Pharmaceuticals
Presentation 11: Advancement of microneedle
Harshil Parikh
Principal Product Development Scientist
Teva Pharmaceuticals
Coffee Break & Networking Session
Presentation 12: Developing Strategic Operational Excellence Roadmap for R&D
Vatsala Sadasivan
Global Operational Excellence Lead, R&D
Sanofi
Presentation 13: Pharmacovigilance in crisis: drug safety at a crossroads
Ram Vempati
Former Head of Pharmacovigilance
Arcellx
Chair Closing Remarks
Leo Kirkovsky
Director, Clinical Assay Group (CAG)